adjusted error rate (a9) for the six subsequent planned pairwise comparisons was 0.009. n = 8 PIs for each group.
The administration of leptin 1 to leptin-de®cient humans, and the analogous Lep ob /Lep ob mice, effectively reduces hyperphagia and obesity 2, 3 . But common obesity is associated with elevated leptin, which suggests that obese humans are resistant to this adipocyte hormone. In addition to regulating long-term energy balance, leptin also rapidly affects neuronal activity 4±6 . Proopiomelanocortin (POMC) and neuropeptide-Y types of neurons in the arcuate nucleus of the hypothalamus 7 are both principal sites of leptin receptor expression and the source of potent neuropeptide modulators, melanocortins and neuropeptide Y, which exert opposing effects on feeding and metabolism 8, 9 . These neurons are therefore ideal for characterizing leptin action and the mechanism of leptin resistance; however, their diffuse distribution makes them dif®cult to study. Here we report electrophysiological recordings on POMC neurons, which we identi®ed by targeted expression of green¯uorescent protein in transgenic mice. Leptin increases the frequency of action potentials in the anorexigenic POMC neurons by two mechanisms: depolarization through a nonspeci®c cation channel; and reduced inhibition by local orexigenic neuropeptide-Y/GABA (g-aminobutyric acid) neurons. Furthermore, we show that melanocortin peptides have an autoinhibitory effect on this circuit. On the basis of our results, we propose an integrated model of leptin action and neuronal architecture in the arcuate nucleus of the hypothalamus.
Previous studies suggest that leptin does not have equal effects on all neuronal subtypes. Acute leptin treatment presumably activates POMC, but not neuropeptide Y (NPY) neurons in the arcuate nucleus of the hypothalamus (ARC), because c-Fos protein is increased only in the former population and Socs3 messenger RNA is increased in both 10 . Furthermore, a population of ARC neurons seems to be inhibited directly by leptin, but the peptide phenotype of these neurons has not been directly established 11±14 . In addition to leptin receptors, both POMC and NPY neurons express a receptor, MC3-R, for POMC-derived melanocortin peptides 15 . The physiological role of this receptor is not well understood, although MC3-R null mice have increased adiposity compared with wild-type mice 16 . To test the hypothesis that leptin selectively activates POMC neurons, we ®rst generated a strain of transgenic mice expressing green¯uorescent protein (EGFP; Clontech) under the transcriptional control of mouse Pomc genomic sequences, including a region located between -13 kilobases (kb) and -2 kb that is required for accurate neuronal expression 17 (Fig. 1a) . Bright green¯uores-cence (509 nm) was seen in the two central nervous system regions where POMC is produced: the ARC and the nucleus of the solitary tract (data not shown).
Under ultraviolet (450±480 nm) excitation, POMC neurons were clearly distinguished from adjacent, non-¯uorescent neurons (Fig.  1b) visualized under infrared optics. Double immuno¯uorescence showed that there was more than 99% cellular colocalization of EGFP and POMC peptides in the ARC (Fig. 1c) . There was close apposition of both tyrosine-hydroxylase-and NPY-stained terminals on EGFP-expressing POMC neurons, but no evidence of colocalization of the tyrosine hydroxylase or NPY immunoreactivity with EGFP (data not shown). Total¯uorescent cell counts of coronal hypothalamic sections determined that there were 3,148 6 62 (mean 6 s.e.m.; n = 3) POMC-EGFP neurons distributed through the whole ARC 18 (Fig. 1d) . POMC neurons are located both medially and ventrally in mouse ARC, in contrast to a predominantly lateral position in rat ARC.
POMC-EGFP neurons in hypothalamic slices had a resting membrane potential of -40 to -45 mV and exhibited frequent spontaneous action potentials. The non-selective opioid agonist met-enkephalin (Met-Enk, 30 mM; Sigma) caused a rapid (35± 40 s), reversible hyperpolarization (10±20 mV) of the membrane potential of POMC cells (n = 10) and prevented spontaneous action potential generation (Fig. 2a) . In normal (2.5 mM K + ) Krebs solution, the reversal potential of the inwardly rectifying opioid current was about -90 mV, whereas in 6.5 mM K + Krebs solution the reversal potential shifted to about -60 mV (n = 3; Fig. 2b) . The mopioid receptor (MOP-R) antagonist CTAP (1 mM; Phoenix Pharmaceuticals) completely prevented the current induced by Met-Enk in POMC cells (n = 3; Fig. 2c ). These characteristics indicate that the opioid current was caused by both activation of MOP-R and increased ion conductance through G-protein-coupled, inwardly rectifying potassium channels 19 . The similarity of opioid responses in EGFP-labelled POMC neurons to those of guinea-pig 19 mouse 20 POMC cells, identi®ed by post-recording immunohistochemistry, suggests that expression of the EGFP transgene does not compromise expression of receptors nor their coupling to second messenger systems in POMC neurons.
We next determined the direct effects of leptin on identi®ed POMC cells in slice preparations. Leptin (0.1±100 nM) depolarized 72 out of 77 POMC cells by 3±30 mV ( Fig. 3a ; depolarization at 100 nM leptin, 9.7 6 1.2 mV (mean 6 s.e.m.; n = 45)) in 2±10 min, in a concentration-responsive manner (Fig. 3b ). There were two components to the depolarization and neither were fully reversible within 40 min. First, the depolarization was due to a small inward current that reversed at about -20 mV (Fig. 3c) , suggesting the involvement of a nonspeci®c cation channel 21 . Second, leptin treatment decreased the GABA-mediated tone onto POMC cells. GABA-mediated inhibitory postsynaptic currents (IPSCs) were observed in POMC cells, and leptin (100 nM) decreased their frequency by 25% (Fig. 3d ) in 5 out of 15 cells, indicating that it may act presynaptically to reduce GABA release (leptin had no effect on IPSCs in 10 out of 15 POMC neurons).
The effect on IPSC frequency occurred with a similar lag to the effect on membrane potential. Thus, leptin not only directly depolarizes POMC neurons but also acts at GABA-secreting nerve terminals to reduce the release of GABA onto POMC neurons, allowing them to adopt a more depolarized resting potential. The consistent depolarization of POMC cells by leptin was speci®c because leptin had no effect on 5 out of 13 adjacent non-¯uorescent cells tested (Fig. 3e) , whereas it hyperpolarized ®ve (Fig. 3f) and depolarized three other non-POMC neurons in the ARC (data not shown). The electrophysiological effects of leptin reported here are consistent with leptin's biological actionsÐleptin rapidly causes release of a-melanocyte-stimulating hormone (a-MSH) from rat hypothalami 4 , presumably by activating POMC neurons. Previous reports of neuronal hyperpolarization by leptin 11, 12 and the colocalization of GABA and NPY 22 in subpopulations of ARC neurons led us to speculate that leptin hyperpolarizes NPY/GABA cells that directly innervate POMC neurons, and thus reduces GABA-mediated drive onto POMC cells. Both leptin and NPY Y2 receptors are expressed on NPY neurons in the ARC 7, 23 . Furthermore, activation of Y2 receptors inhibits NPY release from NPY neurons 24 , and presumably would also diminish GABA release from NPY/GABA terminals. This provided us with an alternative pharmacological approach, independent of leptin, to test the proposed innervation of POMC neurons by GABA-secreting NPY neurons.
Indeed, NPY (100 nM; Bachem) decreased the frequency of GABA-mediated IPSCs by 55% in 3 min in all 12 POMC cells tested (Fig. 4a) . Both NPY and leptin still inhibited IPSCs in the presence of tetrodotoxin (TTX; 6/6 and 3/5 cells, respectively), indicating that some of the inhibition of IPSCs was occurring through direct effects at presynaptic nerve terminals. POMC neurons express the NPY Y1 receptor 23 , and NPYalso hyperpolarized all POMC neurons tested by an average of 9 6 6 mV (n = 3; data not shown).
To con®rm the origin of GABA-mediated innervation on POMC neurons from NPY/GABA terminals, we also tested the effect of the highly selective MC3-R agonist D-Trp 8 -gMSH (ref. 25) on local GABA release. D-Trp 8 -gMSH (7 nM) increased the frequency of GABA-mediated IPSCs (280 6 90%) recorded from three out of four POMC neurons (Fig. 4b) . It had no effect on one cell. The positive effect of MC3-R activation, together with the negative effects of NPY and leptin, shows the dynamic range of the NPY/ GABA synapse onto POMC neurons and points to the important role of this synapse in modulating signal¯ow in the ARC. D-Trp 8 -gMSH (7 nM) also hyperpolarized (-5.5 6 2.4 mV) 9 out of 15 POMC neurons tested, and decreased the frequency of action potentials (Fig. 4c) ; the remaining cells showed no signi®cant response to D-Trp 8 -gMSH. We could not determine whether these effects were entirely due to increased GABA release onto the POMC cells, or whether there was an additional postsynaptic action of DTrp 8 -gMSH on POMC neurons, roughly half of which also express the MC3-R 15 . Thus, MC3-R acts in a similar autoreceptor manner to MOP-Rs on POMC neurons, diminishing POMC neuronal activity in response to elevated POMC peptides.
To determine that the IPSCs in POMC neurons were due to local innervation by NPY/GABA cells, we carried out multi-label immuno- histochemistry using light and electron microscopy. Although independent NPY 27 and GABA 27 innervation of POMC cells has been reported, colocalization of NPY and GABA in nerve terminals forming synapses onto POMC cells has not been shown. Similar to the rat 26 , a dense innervation of POMC cells by NPY axon terminals was detected in the mouse (Fig. 4d) . Electron microscopy con®rmed the co-expression of NPYand GABA in axon terminals, and showed that these boutons established synapses on the perikarya of all 15 ARC POMC neurons analysed (Fig. 4e) .
These observations allow us to propose a detailed model of regulation of this circuit including: dual mechanisms of leptin action in the ARC, interactions between NPY/GABA and POMC neurons, and autoregulatory feedback from opioid and melanocortin peptides as well as NPY (Fig. 4f) . In this model, leptin directly depolarizes the POMC neurons while simultaneously hyperpolarizing the somata of NPY/GABA neurons, and diminishes release from NPY/GABA terminals. This diminished GABA release disinhibits the POMC neurons. Together, the direct and indirect effects of leptin result in an activation of POMC neurons and an increased frequency of action potentials. In addition, both POMC and NPY neurons express autoreceptors for some of their respective neuropeptide products (b-endorphin or a-MSH, and NPY, respectively) and activation of these autoreceptors may provide ultrashort feedback loops that further modulate the effects of leptin on POMC neurons. The effects of NPY and melanocortin agonists on IPSC frequency are similar to the effect of NPY on IPSCs in the paraventricular nucleus of the hypothalamus 28 . Thus, there seem to be two classes of neurons accounting for leptin sensitivity in the brain: those activated (depolarized) to release anorexigenic peptides; and those inhibited (hyperpolarized) with a consequent reduction in release of orexigenic peptides. Identifying viable POMC neurons with EGFP provides an invaluable tool for determining complex actions on these important neurons. Furthermore, an understanding of the acute effects of leptin provides a model system for studying the mechanisms underlying the development of leptin resistance 29 .
M

Methods
Generation of POMC-EGFP mice
The EGFP cassette contains its own Kozak consensus translation initiation site, along with SV40 polyadenylation signals downstream of the EGFP coding sequences, which directs proper processing of the 39 end of the EGFP mRNA. We introduced the EGFP cassette by standard techniques into the 59 untranslated region of exon 2 of a mouse Pomc genomic clone containing 13 kb of 59 and 2 kb of 39¯anking sequences 17 . The transgene was microinjected into pronuclei of one-cell-stage embryos of C57BL/6J mice (Jackson Laboratories) as described 17 . One founder was generated and bred to wild-type C57BL/6J to produce N 1 hemizygous mice. In addition, we also generated N 2 and subsequent generations of mice homozygous for the transgene. The mice are fertile and have normal growth and development.
Immuno¯uorescence and GFP colocalization
Anaesthetized mice were perfused transcardially with 4% paraformaldehyde, and freeoating brain sections were prepared with a vibratome. We processed sections for immuno¯uoresence and colocalization of GFP¯uoresence using standard techniques. Primary antisera and their ®nal dilutions were rabbit anti-b-endorphin, 1:2500 (v/v); rabbit anti-NPY, 1:25,000 (v/v) (Alanex Corp.); rabbit anti-ACTH, 1:2000 (v/v); and mouse anti-TH, 1:1000 (v/v) (Incstar). After rinsing, sections were incubated with 10 mg ml -1 biotinylated horse anti-mouse/rabbit immunoglobulin-g (IgG) (Vector Laboratories) followed by Cy-3 conjugated streptavidin, 1:500 (v/v) (Jackson Immunoresearch Laboratories). Photomicrographs were taken on an Axioscop (Zeiss) usinḡ uoroscein isothiocyanate (FITC) and rhodamine isothiocyanate (RITC) ®lter sets (Chroma Technology Corp.).
Electrophysiology
We cut 200-mm thick coronal slices from the ARC of 4-week-old male POMC-EGFP mice. Slices were maintained at 35 8C in Krebs solution ((in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl 2 , 2.4 CaCl 2 .2H 2 O, 1.2 NaH 2 PO 4 .H 2 O, 21.4 NaHCO 3 , 11.1 glucose), and were saturated with 95% O 2 5% CO 2 for 1 h before recordings. Recordings were made in Krebs solution at 35 8C. Slices were visualized on an Axioskop FS2 (Zeiss) through standard infrared optics and using epi¯uoresence through a FITC ®lter set (see Fig. 1c ). Whole-cell recordings were made from¯uorescent neurons using an Axopatch 1D ampli®er (Axon Instruments) and Clampex 7 (Axon Instruments).
We determined resting membrane potentials using an event-detection protocol on a PowerLab system (AD Instruments) to average expanded traces of the membrane potential. Drugs were applied to the bath over the times indicated. The resting membrane potential was stable for up to 1 h in cells treated with Krebs solution alone (data not shown). I±V relationships for the Met-Enk currents were established using a step protocol (-60 mV holding potential, sequentially pulsed (40 ms) from -120 to -50 mV; cells were returned to -60 mV for 2 s between voltage steps). The protocol was repeated after addition of Met-Enk. The net current was the difference between the two I±V relation- ships. This protocol was repeated in Krebs solution with 6.5 mM K + . To identify the postsynaptic leptin current, I±V relationships were performed similarly with slow voltage ramps (5 mV s -1 from -100 to -20 mV) before and 10 min after adding leptin (100 nM). GABA-mediated IPSCs were recorded using a CsCl internal electrode solution ((in mM): 140 CsCl, 10 HEPES, 5 MgCl 2 , 1 BAPTA, 5 Mg-ATP, 0.3 Na-GTP). Both mini IPSCs and large amplitude (presumably multisynaptic) IPSCs were observed in the untreated slices. TTX (1 mM) abolished large IPSCs. We acquired data before and after drug addition at a -50-mV holding potential in 2-s sweeps every 4 s for the times indicated in the ®gures. Mini-postsynaptic currents were analysed using Axograph 4 (Axon Instruments). IPSCs and excitatory postsynaptic currents (EPSCs) were distinguished on the basis of their decay constants; in addition, picrotoxin (100 mM) blocked all IPSCs. POMC neurons receive a low EPSC tone, and the frequency was not modulated by any of the treatments described here.
Immunostaining for light and electron microscopy
We carried out double immunocytochemistry for NPY and POMC using different colour diaminobenzidine (DAB) chromogens on ®xed mouse hypothalami according to published protocols 27 . For electron microscopy, pre-embedding immunostaining for bendorphin was done with an ABC Elite kit (Vector Laboratories) and a DAB reaction, followed by post-embedding labelling of GABA and NPY using rabbit anti-GABA, 1:1000 (v/v), and gold-conjugated (10-nm) goat anti-rabbit IgG or sheep anti-NPY and goldconjugated (25-nm) goat anti-sheep IgG. Sections were contrasted with saturated uranyl acetate (10 min) and lead citrate (20±30 s), and examined using a Philips CM-10 electron microscope. Acute modulation of P/Q-type (a 1A ) calcium channels by neuronal activity-dependent changes in intracellular Ca 2+ concentration may contribute to short-term synaptic plasticity 1±3 , potentially enriching the neurocomputational capabilities of the brain 4, 5 . An unconventional mechanism for such channel modulation has been proposed 6, 7 in which calmodulin (CaM) may exert two opposing effects on individual channels, initially promoting (`facilitation') and then inhibiting (`inactivation') channel opening. Here we report that such dual regulation arises from surprising Ca 2+ -transduction capabilities of CaM. First, although facilitation and inactivation are two competing processes, both require Ca 2+ -CaM binding to a single`IQ-like' domain on the carboxy tail of a 1A 8 ; a previously identi®ed`CBD' CaM-binding site 6, 7 has no detectable role. Second, expression of a CaM mutant with impairment of all four of its Ca 2+ -binding sites (CaM 1234 ) eliminates both forms of modulation. This result con®rms that CaM is the Ca 2+ sensor for channel regulation, and indicates that CaM may associate with the channel even before local Ca 2+ concentration rises. Finally, the bifunctional capability of CaM arises from bifurcation of Ca 2+ signalling by the lobes of CaM: Ca 2+ binding to the amino-terminal lobe selectively initiates channel inactivation, whereas Ca 2+ sensing by the carboxyterminal lobe induces facilitation. Such lobe-speci®c detection provides a compact means to decode local Ca 2+ signals in two ways, and to separately initiate distinct actions on a single molecular complex.
To simplify the dissection of the molecular mechanisms, we studied recombinant P/Q-type (a 1A /b 2a /a 2 d) channels expressed in mammalian HEK293 cells. Figure 1a shows that Ca 2+ -dependent
